Home/Investors/Uniseed

Uniseed

Biotech Investor · 7 portfolio companies

Portfolio

7

Focus Areas

11

Top Stage

phase-2

Investment Focus

Central Nervous System Pain Substance Use Disorder Respiratory Infectious Diseases Immunology Oncology Fibrosis Nephrology Neurology Ophthalmology Retinal Vascular Diseases

Portfolio Companies

Company	Stage	Valuation	Focus
Kinoxis Therapeutics	phase-2	—	Central Nervous System, Pain
ENA Respiratory	phase-2	—	Respiratory Infectious Diseases, Immunology
Currus Biologics	preclinical	—	Oncology, Immunology
Certa Therapeutics	Phase-2	—	Fibrosis, Nephrology
Axelia Oncology	phase-1	—	Oncology, Immunology
Lucia Bio	preclinical	—	Immunology, Neurology
Exonate	Phase 2	—	Ophthalmology, Retinal Vascular Diseases

Frequent Co-Investors

Brandon Capital2 shared Main Sequence Ventures1 shared Medical Research Commercialisation Fund1 shared UniSuper1 shared University of Sydney1 shared Stoic VC1 shared Avicella Capital1 shared CUREator+ grant (Australian Government)1 shared